Works matching IS 17762596 AND DT 2013 AND VI 8 AND IP 4

Results: 14

Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 295, doi. 10.1007/s11523-012-0243-8

By:

Italiano, A.;
Saada, E.;
Cioffi, A.;
Poulette, S.;
Bouchet, S.;
Molimard, M.;
Adenis, A.;
Isambert, N.;
Collard, O.;
Le Cesne, Axel;
Maki, Robert G.;
Bui, B.

Publication type:

Article

Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.

Published in:

2013

By:

Italiano, A;
Saada, E;
Cioffi, A;
Poulette, S;
Bouchet, S;
Molimard, M;
Adenis, A;
Isambert, N;
Collard, O;
Le Cesne, Axel;
Maki, Robert G;
Bui, B

Publication type:

journal article

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer.

Published in:

2013

By:

Shimizu, Katsuhiko;
Yukawa, Takuro;
Hirami, Yuji;
Okita, Riki;
Saisho, Shinsuke;
Maeda, Ai;
Yasuda, Koichiro;
Nakata, Masao

Publication type:

journal article

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 237, doi. 10.1007/s11523-012-0241-x

By:

Shimizu, Katsuhiko;
Yukawa, Takuro;
Hirami, Yuji;
Okita, Riki;
Saisho, Shinsuke;
Maeda, Ai;
Yasuda, Koichiro;
Nakata, Masao

Publication type:

Article

Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 253, doi. 10.1007/s11523-012-0248-3

By:

van de Luijtgaarden, A. C. M.;
Versleijen-Jonkers, Y. M. H.;
Roeffen, M. H. S.;
Schreuder, H. W. B.;
Flucke, U. E.;
van der Graaf, W. T. A.

Publication type:

Article

Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma.

Published in:

2013

By:

Morales La Madrid, Andres;
Campbell, Nicholas;
Smith, Sonali;
Cohn, Susan L.;
Salgia, Ravi

Publication type:

Correction Notice

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 281, doi. 10.1007/s11523-013-0264-y

By:

Jaszberenyi, Miklos;
Schally, Andrew V.;
Block, Norman L.;
Zarandi, Marta;
Cai, Ren-Zhi;
Vidaurre, Irving;
Szalontay, Luca;
Jayakumar, Arumugam R.;
Rick, Ferenc G.

Publication type:

Article

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 243, doi. 10.1007/s11523-012-0242-9

By:

Trédan, Olivier;
Treilleux, Isabelle;
Wang, Qing;
Gane, Nicolas;
Pissaloux, Daniel;
Bonnin, Nathalie;
Petit, Thierry;
Cretin, Jacques;
Bonichon-Lamichhane, Nathalie;
Priou, Frank;
Lavau-Denes, Sandrine;
Mari, Véronique;
Freyer, Gilles;
Lebrun, Daniela;
Alexandre, Jérôme;
Ray-Coquard, Isabelle

Publication type:

Article

Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 291, doi. 10.1007/s11523-012-0240-y

By:

Petrelli, Fausto;
Borgonovo, Karen;
Lonati, Veronica;
Elia, Stefano;
Barni, Sandro

Publication type:

Article

Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 271, doi. 10.1007/s11523-013-0253-1

By:

Lee, Su Jin;
Do, In-Gu;
Lee, Jeeyun;
Kim, Kyoung-Mee;
Jang, Jiryeon;
Sohn, Insuk;
Kang, Won Ki

Publication type:

Article

Follistatin as potential therapeutic target in prostate cancer.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 215, doi. 10.1007/s11523-013-0268-7

By:

Sepporta, Maria Vittoria;
Tumminello, Francesca Maria;
Flandina, Carla;
Crescimanno, Marilena;
Giammanco, Marco;
La Guardia, Maurizio;
di Majo, Danila;
Leto, Gaetano

Publication type:

Article

GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 225, doi. 10.1007/s11523-012-0234-9

By:

Delie, Florence;
Petignat, Patrick;
Cohen, Marie

Publication type:

Article

High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 231, doi. 10.1007/s11523-012-0239-4

By:

Imano, Motohiro;
Itoh, Tatsuki;
Satou, Takao;
Yasuda, Atsushi;
Nishiki, Kohei;
Kato, Hiroaki;
Shiraishi, Osamu;
Peng, Ying-Feng;
Shinkai, Masayuki;
Tsubaki, Masahiro;
Yasuda, Takushi;
Imamoto, Haruhiko;
Nishida, Shozo;
Takeyama, Yoshifumi;
Furkawa, Hiroshi;
Okuno, Kiyokata;
Shiozaki, Hitoshi

Publication type:

Article

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.

Published in:

Targeted Oncology, 2013, v. 8, n. 4, p. 261, doi. 10.1007/s11523-012-0249-2

By:

el Sayadi, Hiba;
Pissaloux, Daniel;
Alberti, Laurent;
Tabone-Eglinger, Severine;
Ranchere, Dominique;
Decouvelaere, Anne Valérie;
Tabone, Eric;
Ray-Coquard, Isabelle;
Caux, Christophe;
Fayette, Jérome;
Blay, Jean-Yves

Publication type:

Article

Works matching IS 17762596 AND DT 2013 AND VI 8 AND IP 4

Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.

Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer.

Heterogeneity of the <i>EGFR</i> mutation status between the primary tumor and metastatic lymph node and the sensitivity to <i>EGFR</i> tyrosine kinase inhibitor in non-small cell lung cancer.

Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients.

Erratum to: Targeting <i>ALK</i>: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma.

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.

Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer.

Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors.

Follistatin as potential therapeutic target in prostate cancer.

GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78.

High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer.

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.